Foundation Medicine and Novartis Collaborate

Xconomy Boston — 

Foundation Medicine, a Cambridge, MA-based personalized cancer medicine firm, said today it will conduct a pilot collaboration with the drug giant Novartis. The companies will work together to optimize Foundation’s cancer genome panel to fit Novartis’s needs, according to Foundation. Based on the pilot, Foundation and Novartis will determine whether to commercialize the test. The firms did not disclose financial details of the arrangement.